COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 2613: Articles 26121-26130  | Next

Suppressive myeloid cells are a hallmark of severe COVID-19
Schulte-Schrepping, J., Reusch, N., Paclik, D., Bassler, K., Schlickeiser, S., Zhang, B., Krämer, B., Krammer, T., Brumhard, S., Bonaguro, L., De Domenico, E., Wendisch, D., Grasshoff, M., Kapellos, T. S., Beckstette, M., Pecht, T., Saglam, A., Dietrich, O., Mei, H. E., Schulz, A. R., Conrad, C., Kunkel, D., Vafadarnejad, E., Xu, C.-J., Horne, A., Herbert, M., Drews, A., Thibeault, C., Pfeiffer, M., Hippenstiel, S., Hocke, A., Müller-Redetzky, H., Heim, K.-M., Machleidt, F., Uhrig, A., de Jarcy, L. B., Jürgens, L., Stegemann, M., Glösenkamp, C. R., Volk, H.-D., Goffinet, C., Raabe, J., Kaiser, K. M., To Vinh, M., Rieke, G., Meisel, C., Ulas, T., Becker, M., Geffers, R., Witzenrath, M., Drosten, C., Suttorp, N., von Kalle, C., Kurth, F., Händler, K., Schultze, J. L., Aschenbrenner, A. C., Li, Y., Nattermann, J., Sawitzki, B., Saliba, A.-E., Sander, L. E., Deutsche COVID-19 OMICS Initiative (DeCOI)
10.1101/2020.06.03.20119818 — Posted: 2020-06-05 Discussion: Onsite | Offsite
A CRISPR-Cas12a-based specific enhancer for more sensitive detection of SARS-CoV-2 infection
Huang, W., Yu, L., Wen, D., Wei, D., Sun, Y., Zhao, H., Ye, Y., Chen, W., Zhu, Y., Wang, L., Wang, L., Wu, W., Zhao, Q., Xu, Y., Gu, D., Nie, G., Zhu, D., Guo, Z., Ma, X., Niu, L., Huang, Y., Liu, Y., Peng, B., Zhang, R., Zhang, X., Li, D., Liu, Y., Yang, G., Liu, L., Zhou, Y., Wang, Y., Hou, T., Gao, Q., Li, W., Chen, S., Hu, X., Han, M., Zheng, H., Wen, J., Cai, Z., Zhang, X., Song, F., Zhao, G., Wang, J.
10.1101/2020.06.02.20119735 — Posted: 2020-06-05
Disparities in COVID-19 related knowledge, attitudes, beliefs and behaviours by health literacy
McCaffery, K., Dodd, R. H., Cvejic, E., Ayre, J., Batcup, C., Isautier, J. M., Copp, T., Bonner, C., Pickles, K., Nickel, B., Dakin, T., Cornell, S., Wolf, M. S.
10.1101/2020.06.03.20121814 — Posted: 2020-06-05
Tocilizumab for patients with COVID-19 pneumonia. The TOCIVID-19 phase 2 trial
Perrone, F., Piccirillo, M. C., Ascierto, P. A., Salvarani, C., Parrella, R., Marata, A. M., Popoli, P., Ferraris, L., Marrocco Trischitta, M. M., Ripamonti, D., Binda, F., Bonfanti, P., Squillace, N., Castelli, F., Muiesan, M. L., Lichtner, M., Calzetti, C., Salerno, N. D., Atripaldi, L., Cascella, M., costantini, m., Dolci, G., Facciolongo, N. C., Fraganza, F., Massari, M., Montesarchio, V., Mussini, C., Negri, E. A., Botti, G., Cardone, C., Gargiulo, P., Gravina, A., Schettino, C., Arenare, L., Chiodini, P., Gallo, C.
10.1101/2020.06.01.20119149 — Posted: 2020-06-05
Paediatric Dentistry and the coronavirus (COVID-19) response in the North East of England and North Cumbria
Simpsons, S., Sumner, O., Holliday, R., Currie, C. C., Hind, V., Lush, N., Burbridge, L., Cole, B.
10.1101/2020.06.02.20114967 — Posted: 2020-06-05
Augmenting contact matrices with time-use data for fine-grained intervention modelling of disease dynamics: A modelling analysis
van Leeuwen, E., PHE Joint modelling group, , Sandmann, F.
10.1101/2020.06.03.20067793 — Posted: 2020-06-05
Characteristics and Outcomes of Hospitalized Young Adults with Mild to Moderate Covid-19 at a University Hospital in India
Sharma, A. K., Ahmed, A., Baig, V. N., Dhakad, P., Dalela, G., Kacker, S., Panwar, V. R., Panwar, R. B., Gupta, R.
10.1101/2020.06.02.20106310 — Posted: 2020-06-05
How Should Clinicians Interpret Imprecise Trials Assessing Drugs for COVID-19 Patients?
Manski, C. F., Tetenov, A.
10.1101/2020.05.26.20114009 — Posted: 2020-06-05
Estimating the parameters of SIR model of COVID-19 cases in India during lock down periods
BAGAL, D. K., RATH, A., Barua, A., Patnaik, D.
10.1101/2020.06.03.20120899 — Posted: 2020-06-04
Integrated genomic view of SARS-CoV-2 in India
Kumar, P., Pandey, R., Sharma, P., Dhar, M., Vivekanand, A., Bharathram, U., Vashistha, H., Wadhwa, S., Tyagi, N., Fatihi, S., Sharma, U., Singh, P., Lall, H., Datta, M., Gupta, P., Saini, N., Tiwari, A., Nandi, B., Kumar, D., Bag, S., Deepanshi, D., Rathore, S., Jatana, N., Jaiswal, V., Gogia, H., Madan, P., Singh, S., Singh, P., Dash, D., Bala, M., Kabra, S., Singh, S. K., Mukerji, M., Thukral, L., Faruq, M., Agarwal, A., Rakshit, P.
10.1101/2020.06.04.128751 — Posted: 2020-06-04 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).